Tenaya Therapeutics
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $167M
Investors
- 8
About Tenaya Therapeutics
Based in California, US, and founded in 2016, Tenaya Therapeutics, Inc. operates as a biopharmaceutical company that utilizes regeneration, gene therapy, and precision medicine platforms in developing therapies for the treatment of heart diseases., Bruce R., and Benoit G.D. Faraz Ali is the CEO of the company as of August 2021. The company's line of products includes a regeneration platform that focuses on developing a treatment for cardiomyocytes and cardiac fibroblasts. The Gene therapy platform focuses on the treatment of genetic hypertrophic cardiomyopathy (HCM). And a precision medicine platform that focuses on developing a small molecule therapy against an unnamed target and has demonstrated compelling in vivo efficacy in a model for genetic dilated cardiomyopathy (DCM). Tenaya Therapeutics plans to accelerate the pipeline of potentially curative therapies for heart disease.
Who invested in Tenaya Therapeutics
8 investors across 3 rounds
See all investors in Tenaya Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tenaya Therapeutics
Who invested in Tenaya Therapeutics?
Tenaya Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tenaya Therapeutics raised?
Tenaya Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tenaya Therapeutics last raise money?
Tenaya Therapeutics's most recent round on record is a Series C, in Dec 2020.
What does Tenaya Therapeutics do?
Based in California, US, and founded in 2016, Tenaya Therapeutics, Inc.
Where is Tenaya Therapeutics headquartered?
Tenaya Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Tenaya Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tenaya Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Tenaya Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.